130 related articles for article (PubMed ID: 20546886)
21. Axial skeletal and Hox expression domain alterations induced by retinoic acid, valproic acid, and bromoxynil during murine development.
Kawanishi CY; Hartig P; Bobseine KL; Schmid J; Cardon M; Massenburg G; Chernoff N
J Biochem Mol Toxicol; 2003; 17(6):346-56. PubMed ID: 14708090
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn).
Theunissen PT; Robinson JF; Pennings JL; de Jong E; Claessen SM; Kleinjans JC; Piersma AH
Toxicol Sci; 2012 Feb; 125(2):430-8. PubMed ID: 22045034
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos [corrected].
Bennett GD; Wlodarczyk B; Calvin JA; Craig JC; Finnell RH
Reprod Toxicol; 2000; 14(1):1-11. PubMed ID: 10689198
[TBL] [Abstract][Full Text] [Related]
24. Tissue-specific effects of valproic acid on DNA repair genes and apoptosis in postimplantation mouse embryos.
Lamparter C; Winn LM
Toxicol Sci; 2014 Sep; 141(1):59-67. PubMed ID: 24913804
[TBL] [Abstract][Full Text] [Related]
25. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Massa V; Wlodarczyk B; Giavini E; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
[TBL] [Abstract][Full Text] [Related]
26. Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model.
Finnell RH; Wlodarczyk BC; Craig JC; Piedrahita JA; Bennett GD
Am J Med Genet; 1997 Jun; 70(3):303-11. PubMed ID: 9188671
[TBL] [Abstract][Full Text] [Related]
27. Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.
Fisher JE; Acuff-Smith KD; Schilling MA; Nau H; Vorhees CV
Teratology; 1994 Jun; 49(6):479-86. PubMed ID: 7747269
[TBL] [Abstract][Full Text] [Related]
28. Valproic acid-induced changes in gene expression during neurulation in a mouse model.
Wlodarczyk BC; Craig JC; Bennett GD; Calvin JA; Finnell RH
Teratology; 1996 Dec; 54(6):284-97. PubMed ID: 9098922
[TBL] [Abstract][Full Text] [Related]
29. Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology.
Robinson JF; Theunissen PT; van Dartel DA; Pennings JL; Faustman EM; Piersma AH
Reprod Toxicol; 2011 Sep; 32(2):180-8. PubMed ID: 21664453
[TBL] [Abstract][Full Text] [Related]
30. Teratogenicity of valproate conjugates with anticonvulsant activity in mice.
Spiegelstein O; Chatterjie N; Alexander G; Finnell RH
Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055
[TBL] [Abstract][Full Text] [Related]
31. Developmentally regulated promoters from Dictyostelium discoideum as molecular markers for testing potential teratogens.
Tillner J; Winckler T; Dingermann T
Pharmazie; 1996 Nov; 51(11):902-6. PubMed ID: 8985980
[TBL] [Abstract][Full Text] [Related]
32. Rat embryos express transcripts for cyclooxygenase-1 and carbonic anhydrase-4, but not for cyclooxygenase-2, during organogenesis.
Streck RD; Kumpf SW; Ozolins TR; Stedman DB
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):57-69. PubMed ID: 12852484
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous gene quantitation of multiple genes in individual bovine nuclear transfer blastocysts.
Smith C; Berg D; Beaumont S; Standley NT; Wells DN; Pfeffer PL
Reproduction; 2007 Jan; 133(1):231-42. PubMed ID: 17244749
[TBL] [Abstract][Full Text] [Related]
34. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
[TBL] [Abstract][Full Text] [Related]
35. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice.
Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomics analysis of retinoic acid embryotoxicity in rat postimplantation whole embryo culture.
Luijten M; van Beelen VA; Verhoef A; Renkens MF; van Herwijnen MH; Westerman A; van Schooten FJ; Pennings JL; Piersma AH
Reprod Toxicol; 2010 Sep; 30(2):333-40. PubMed ID: 20488242
[TBL] [Abstract][Full Text] [Related]
37. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo.
Selderslaghs IW; Van Rompay AR; De Coen W; Witters HE
Reprod Toxicol; 2009 Nov; 28(3):308-20. PubMed ID: 19447169
[TBL] [Abstract][Full Text] [Related]
38. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos.
Wlodarczyk BJ; Cabrera RM; Hill DS; Bozinov D; Zhu H; Finnell RH
Neurotoxicology; 2006 Jul; 27(4):547-57. PubMed ID: 16620997
[TBL] [Abstract][Full Text] [Related]
39. Suppressed expression of genes involved in transcription and translation in in vitro compared with in vivo cultured bovine embryos.
Corcoran D; Fair T; Park S; Rizos D; Patel OV; Smith GW; Coussens PM; Ireland JJ; Boland MP; Evans AC; Lonergan P
Reproduction; 2006 Apr; 131(4):651-60. PubMed ID: 16595716
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
